Navigation Links
ALS Therapy Development Institute Receives $1.6 Million Grant From the Department of Defense for Lou Gehrig's Disease Research
Date:1/12/2010

ALS (Lou Gehrig's disease) named Service Related Disorder Earlier Last Year

CAMBRIDGE, Mass., Jan. 12 /PRNewswire-USNewswire/ -- In recognition of multiple studies connecting ALS to military service, the 2010 Defense Appropriations Act, signed by President Obama on December 22, 2009, provided for the grant of $1.6 million for research and development of potential therapeutics for Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease).  Deemed a "service-related disorder" by the Veterans Administration (VA) in July of 2008, ALS affects approximately 30,000 Americans at any given time.  With no robust therapeutics currently available, those afflicted survive on average only 36 months from diagnosis.  The funding approved will be sent to the ALS Therapy Development Institute (ALS TDI), a non-profit, independent research center devoted to the development of therapeutics that slow and stop progression of the fatal neurodegenerative disease.

"This grant from the [Department of Defense], bringing their total spent on ALS research at our Institute alone to nearly $5.5 million over a period of five years, shows their commitment to our veterans.  It is unacceptable that those stricken by the disease, for whatever reason, including our servicemen and servicewomen returning from war, do not have therapeutic options available.  We must move faster toward providing truly efficacious interventions for all those living with ALS today," said Steve Perrin, Ph.D., chief executive officer and chief scientific officer at ALS TDI.

The request for spending was sponsored by Congressman Michael Capuano (D-MA).  "C
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MBM ScienceBridge GmbH Negotiates License Agreement Between the Georg-August-University Gottingen, Universitatsmedizin, the University of Regensburg, and the UKs Medical Research Council Technology for a New Therapy of Inflammatory and Immune Disea
2. New hope for therapy in heartburn-related cancer
3. Breast cancer multigene test helping patients avoid chemotherapy
4. Psychotherapy May Help Teen Girls Avoid Obesity
5. After Cochlear Implant, Music Therapy May Aid Speech
6. High antiretroviral therapy adherence associated with lower health care costs
7. Music therapy can assist toddlers communication rehabilitation process
8. UV LED therapy shows promising results in preventing focal seizures
9. Sexual function does not continuously decline after radiation therapy treatments for prostate cancer
10. Ring in a Healthy New Year with Massage Therapy in 2010
11. Lithium Beats Valproate for Long-Term Bipolar Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... According to a new market research report, ... sapphire), Deposition Technology (CVD, MBE, HVPE, Ammonothermal, ... Geography-2013-2020", published by MarketsandMarkets, the market is expected ... 2014 to 2020 and reach $104.55 billion in ... 88 figures spread through 342 pages and in-depth ...
(Date:7/28/2014)... According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 ... at USD 3,005 million in 2014 and is expected ... to 2020, to reach an estimated value of USD ... software market is witnessing significant growth due to increasing ...
(Date:7/28/2014)... July 28, 2014A group of researchers in Taiwan has ... to detect an early complication of diabetes sooner, when ... safe and effective in clinical trials, it may pave ... treatment of this complication, called diabetic autonomic neuropathy, which ... Type 2 diabetes. The condition progressively affects the autonomic ...
(Date:7/28/2014)... July 28, 2014 Axiom EPM ... financial planning and performance management software for enterprises, today ... Q2, achieving results that surpassed its record Q1 results, ... The company attributes this growth to increased demand for ... well as the addition of incremental solutions for existing ...
(Date:7/28/2014)... Humility of Mary Health Partners will offer a one-hour ... Health Center, 8401 Market St., Boardman. , The workshop includes ... 200 common health problems as well as tips on caring ... advice on when to seek medical attention. , The ... session runs from 5:30 to 6:30 p.m. The workshop and ...
Breaking Medicine News(10 mins):Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Axiom EPM Announces Record Second Quarter of 2014 2Health News:HMHP Offers ‘Health at Home’ Workshop 2
... Shopko Eyecare Centers are,proud to announce the addition of ... searching for frames for her then 2-year old daughter, ... a mother to a child with Down,Syndrome. Frustrated with ... of eyeglass frames for children with Down Syndrome and,other ...
... immune cells at work , Immune cells ... asthma. Now, a team of researchers at Massachusetts General ... real-time eosinophil responses in the lungs and airways of ... airway inflammation); they hope that these approaches might be ...
... STE ) is postponing its analyst day scheduled for ... Company believes that,postponing the event until a larger portion ... action at this time. The Company apologizes for,any inconvenience ... STERIS, STERIS Corporation is a leading provider of ...
... N.J., Nov. 6 Pharmos Corporation,(Nasdaq: PARS ) today ... Company recorded a net loss of $2.8 million, or $0.11 ... loss of $3.5 million,or $0.14 per share, in the third ... 30, 2008., The decrease in net loss for the ...
... should start with emergency room doctors, study says , , ... teens who suffer violence at the hands of peers, ... and diffuse threats reduces their risk of becoming victims ... 10- to 15-year-olds treated for assault injuries -- including ...
... Of Growth In Revenues, CARLSBAD, Calif., Nov. ... specialized laboratory services provider, today reported,revenues of $32.1 ... includes a,$2.5 million benefit from changes in accounting ... of $16.2 million for the same period in,2007, ...
Cached Medicine News:Health News:Shopko Announces Erin's World Eyewear 2Health News:JCI online early table of contents: Nov. 6, 2008 2Health News:JCI online early table of contents: Nov. 6, 2008 3Health News:JCI online early table of contents: Nov. 6, 2008 4Health News:JCI online early table of contents: Nov. 6, 2008 5Health News:STERIS Corporation Postpones Analyst Day 2Health News:STERIS Corporation Postpones Analyst Day 3Health News:Pharmos Corporation Reports 2008 Third Quarter Results 2Health News:Pharmos Corporation Reports 2008 Third Quarter Results 3Health News:Pharmos Corporation Reports 2008 Third Quarter Results 4Health News:Pharmos Corporation Reports 2008 Third Quarter Results 5Health News:Counseling Can Combat Youth Violence 2Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 2Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 3Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 4Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 5Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 6Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 7Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 8Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 9Health News:Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008 10
(Date:7/28/2014)... July 28, 2014 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China , ... of Directors declared a special cash dividend of US$0.30 ... ("ADS")) on the Company,s outstanding ordinary shares. The total ...
(Date:7/28/2014)... 28, 2014   Cardioxyl Pharmaceuticals, Inc. announced ... that CXL-1427, a novel potential treatment for acute decompensated ... The company has now initiated dosing of hospitalized patients ... trial designed to further evaluate the drug,s safety and ... The Phase I clinical trial evaluated the safety and ...
(Date:7/28/2014)... 28, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2014 Financial Results and Highlights Conference CallWhen:Monday, August 4 ... How:Live on the Internet. Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... Technologies Inc., the leading developer of non-invasive electrocardiographic ... $7.5 million Series "C" financing.  The proceeds from ... commercial efforts related to its ECVUE ™ ... (Logo: http://photos.prnewswire.com/prnh/20110531/DC10432LOGO ) CardioInsight recently ...
...  MAKScientific, LLC, a privately held company focused on the ... that it has entered into an exclusive, worldwide option ... BIIB ) to develop and commercialize drug candidates for ... diseases. Under the agreement, Biogen Idec will ...
Cached Medicine Technology:CardioInsight Announces Closing of $7.5 Million Equity Financing 2
True/Fix Distal Femoral Nail System...
... cement youre using, the Vortex Vacuum Mixer is ... is stirring up traditional vacuum mixers. The ergonomically ... time. The time-saving crank three revolutions every ... effort and less stirring, cutting down on the ...
... Simple, cost-effective microfiltration for your ... autotransfusion also brings you an easy ... safety of microfiltration for a variety ... or postoperative applications, autologous or homologous ...
... use; perfect tool with power and endurance. ... user fatigue. Internally lubricated for longer serivce. ... it will not break if dropped. Hex ... life by 50% compared to similar competitive ...
Medicine Products: